As the detection of a recurrent TRIM24::MET fusion expands the spectrum of known driving fusion genes in infant-type hemispheric glioma, this comparative illustration may indicate a notable clinico-pathological heterogeneity of tumors bearing this particular molecular driver alteration. Here, MET is linked to glioma.